New oral drug for type 2 diabetes shows promise
The first of a new class of oral antidiabetic drugs is able to lower blood sugar (glucose) in type 2 diabetes as well as Avandia (rosiglitazone) does, but without causing weight gain, according to a report in the journal Diabetes Care. The new agent, vildagliptin, also known by the brand name Galvus, is awaiting regulatory [...]